These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36152071)

  • 1. Value of magnetic resonance imaging/ultrasound fusion prostate biopsy to select patients for focal therapy.
    Ganzer R; Mangold A; Siokou FS; Brinkschmidt C; Brummeisl W
    World J Urol; 2022 Nov; 40(11):2689-2694. PubMed ID: 36152071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIRADS≥4 MRI lesion: Is performing systematic biopsies still essential for detecting clinically significant prostate cancer?
    Taha F; Branchu B; Demichel N; Goudaimy S; Bui AP; Delchet O; Larre S
    Fr J Urol; 2024 Mar; 34(2):102572. PubMed ID: 38330830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
    Lim CS; Abreu-Gomez J; Carrion I; Schieda N
    AJR Am J Roentgenol; 2021 Mar; 216(3):683-690. PubMed ID: 32755208
    [No Abstract]   [Full Text] [Related]  

  • 4. Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study.
    van der Leest M; Cornel E; Israël B; Hendriks R; Padhani AR; Hoogenboom M; Zamecnik P; Bakker D; Setiasti AY; Veltman J; van den Hout H; van der Lelij H; van Oort I; Klaver S; Debruyne F; Sedelaar M; Hannink G; Rovers M; Hulsbergen-van de Kaa C; Barentsz JO
    Eur Urol; 2019 Apr; 75(4):570-578. PubMed ID: 30477981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter transperineal MRI-TRUS fusion guided outpatient clinic prostate biopsies under local anesthesia.
    Jacewicz M; Günzel K; Rud E; Lauritzen PM; Galtung KF; Hinz S; Magheli A; Baco E
    Urol Oncol; 2021 Jul; 39(7):432.e1-432.e7. PubMed ID: 33257219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Upgrading Rates of International Society of Urological Pathology Grades and Tumor Laterality in Patients Undergoing Standard 12-Core Prostate Biopsy versus Fusion Prostate Biopsy for Prostate Cancer.
    Demirtaş A; Sönmez G; Tombul ŞT; Demirtaş T; Akgün H
    Urol Int; 2019; 103(3):256-261. PubMed ID: 31242496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Additive Diagnostic Value of Prostate-specific Membrane Antigen Positron Emission Tomography Computed Tomography to Multiparametric Magnetic Resonance Imaging Triage in the Diagnosis of Prostate Cancer (PRIMARY): A Prospective Multicentre Study.
    Emmett L; Buteau J; Papa N; Moon D; Thompson J; Roberts MJ; Rasiah K; Pattison DA; Yaxley J; Thomas P; Hutton AC; Agrawal S; Amin A; Blazevski A; Chalasani V; Ho B; Nguyen A; Liu V; Lee J; Sheehan-Dare G; Kooner R; Coughlin G; Chan L; Cusick T; Namdarian B; Kapoor J; Alghazo O; Woo HH; Lawrentschuk N; Murphy D; Hofman MS; Stricker P
    Eur Urol; 2021 Dec; 80(6):682-689. PubMed ID: 34465492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy.
    Freifeld Y; Xi Y; Passoni N; Woldu S; Hornberger B; Goldberg K; Bagrodia A; Raj G; Margulis V; Cadeddu JA; Lotan Y; Francis F; Pedrosa I; G Roehrborn C; Costa DN
    Urol Oncol; 2019 Jan; 37(1):57-62. PubMed ID: 30446460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct comparison between Grade Group assessed on systematic and MRI/ultrasound fusion targeted biopsies correlated to the radical prostatectomy specimens in patients with prostate cancer.
    Payrard-Starck C; Fourcade A; An Nguyen T; Tissot V; Doucet L; Marolleau J; Lucas C; Fournier G; Valeri A
    Prog Urol; 2023 Apr; 33(5):265-271. PubMed ID: 36740508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing Spatial Biopsy Sampling for the Detection of Prostate Cancer.
    Raman AG; Sarma KV; Raman SS; Priester AM; Mirak SA; Riskin-Jones HH; Dhinagar N; Speier W; Felker E; Sisk AE; Lu D; Kinnaird A; Reiter RE; Marks LS; Arnold CW
    J Urol; 2021 Sep; 206(3):595-603. PubMed ID: 33908801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging target fusion biopsy vs. transrectal ultrasound-guided biopsy - A comparative study of ISUP score upgrading risk in the final radical prostatectomy specimen.
    Guimarães T; Gil M; Medeiros M; Andrade V; Guerra J; Pinheiro H; Fernandes F; Pina J; Lopes Dias J; Campos Pinheiro L
    Arch Ital Urol Androl; 2022 Sep; 94(3):278-284. PubMed ID: 36165470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1-2 prostate cancer at MRI-targeted biopsy: a multicenter analysis.
    Kesch C; Pantea V; Soeterik T; Marquis A; la Bombarda G; Morlacco A; Barletta F; Radtke JP; Darr C; Preisser F; Zattoni F; Marra G; van den Bergh RCN; Hadaschik B; Gandaglia G;
    World J Urol; 2023 Feb; 41(2):427-434. PubMed ID: 36534151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparametric MRI in men with clinical suspicion of prostate cancer undergoing repeat biopsy: a prospective comparison with clinical findings and histopathology.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
    Acta Radiol; 2018 Mar; 59(3):371-380. PubMed ID: 28679325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy.
    Nassiri N; Chang E; Lieu P; Priester AM; Margolis DJA; Huang J; Reiter RE; Dorey FJ; Marks LS; Natarajan S
    J Urol; 2018 Feb; 199(2):453-458. PubMed ID: 28830754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort.
    Luzzago S; de Cobelli O; Mistretta FA; Piccinelli ML; Lorusso V; Morelli M; Bianchi R; Catellani M; Cozzi G; Di Trapani E; Pricolo P; Alessi S; Ferro M; Marvaso G; Matei DV; Jereczek-Fossa BA; Petralia G; Musi G
    Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):406-413. PubMed ID: 32989259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.
    Kaufmann B; Saba K; Schmidli TS; Stutz S; Bissig L; Britschgi AJ; Schaeren E; Gu A; Langenegger N; Sulser T; Eberli D; Keller EX; Hermanns T; Poyet C
    Prostate; 2022 Feb; 82(3):388-396. PubMed ID: 34914121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical study of multifactorial diagnosis in prostate biopsy.
    Li J; Wang K; Li S; Wu P; Wang X; He Y; Tang W
    Prostate; 2023 Nov; 83(15):1494-1503. PubMed ID: 37545333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is targeted magnetic resonance imaging/transrectal ultrasound fusion prostate biopsy enough for the detection of prostate cancer in patients with PI-RADS ≥3: Results of a prospective, randomized clinical trial.
    Zhang J; Zhu A; Sun D; Guo S; Zhang H; Liu S; Fu Q; Zhang K
    J Cancer Res Ther; 2020; 16(7):1698-1702. PubMed ID: 33565519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
    Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A
    Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transperineal vs transrectal magnetic resonance and ultrasound image fusion prostate biopsy: a pair-matched comparison.
    Kaneko M; Medina LG; Lenon MSL; Hemal S; Sayegh AS; Jadvar DS; Ramacciotti LS; Paralkar D; Cacciamani GE; Lebastchi AH; Salhia B; Aron M; Hopstone M; Duddalwar V; Palmer SL; Gill IS; Abreu AL
    Sci Rep; 2023 Aug; 13(1):13457. PubMed ID: 37596374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.